Spin-out companies have strengthened the linkage between UniSA and industry. The growing number of technology patents and spin-outs coming out of UniSA research has a significant impact on regional, economic and social development.
AbRegen is a preclinical-stage biotechnology company developing first-in class antibody-based therapeutics to treat immuno-inflammatory conditions.Read more
AUCENTRA Therapeutics discovers and develops oral small molecules for a range of cancers.Read more
Carina Biotech is focused on research and IP development in chimeric antigen receptor T cell (CAR-T) technologies.Read more
Cincera Therapeutics is focused on the discovery and development of new drugs aiming to treat inflammatory and fibrotic conditions.Read more
Cohda Wireless is a world leader in Connected Autonomous Vehicle (CAV) technology, making our streets safer, smarter and greener.Read more
Ferronova is developing a system to less invasively and more accurately stage the spread of head and neck cancer.Read more
Myriota are global leaders in low-cost, low-power, secure direct-to-orbit satellite connectivity for the Internet of Things.Read more